Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Prostatic Neoplasms 4Breast Neoplasms 3Pancreatic Neoplasms 2Glioblastoma 2Smoking Cessation 1Quality of Life 1Patient Compliance 1Overweight 1Obesity 1Motor Activity 1Melanoma 1Lung Neoplasms 1Inflammation 1Glioma 1GastroEsophageal Cancer 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Advanced Malignant Solid Neoplasm 1

Interventions

Gemcitabine 57130-nm albumin-bound paclitaxel 35Specimen Handling 26Magnetic Resonance Spectroscopy 21Albumin-Bound Paclitaxel 21Fluorouracil 20Leucovorin 19Irinotecan 19Oxaliplatin 17Biopsy 17Taxes 16pembrolizumab 13Cyclophosphamide 11Cisplatin 11fludarabine 10Cetuximab 9Capecitabine 8Nivolumab 7Carboplatin 7irinotecan sucrosofate 6durvalumab 6dehydroftorafur 6Radiosurgery 6Pemetrexed 6olaparib 5Ipilimumab 5Erlotinib Hydrochloride 5trastuzumab deruxtecan 4aldesleukin 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Diet Therapy × 90 days × Clear all
NCT06090916 2026-05-26

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
100 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07560540 2026-05-01

{ERAS}

University of Veterinary and Animal Sciences, Lahore - Pakistan

Phase NA Recruiting
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡